
Database Lock in Trial for New At-Home Treatment of Agitation in Bipolar Disorders and Schizophrenia
BioXcel Therapeutics advances BXCL501 for at-home treatment of agitation in bipolar disorders and schizophrenia, aiming for FDA approval by 2026.
BioXcel Therapeutics advances BXCL501 for at-home treatment of agitation in bipolar disorders and schizophrenia, aiming for FDA approval by 2026.
According to a new law, humans are essential for appreciating nonverbal information and exercising ethical priorities.
Psychiatry confronts emotional asymmetry, revealing how race and privilege shape emotional expression and affective labor in clinical settings.
Explore the latest research on athlete mental health, highlighting concussion recovery, anti-doping stress, and the protective role of competitive sports.
Understanding decisional capacity is crucial for effective patient care, emphasizing the need for tailored assessments and support to enhance autonomy.
Explore the lasting impact of therapeutic communities on mental health and addiction recovery, highlighting innovative research and community-building strategies.
An expert shares the importance of lived expertise in addressing health care inequities and fostering a deeper understanding of diversity in medical practices.
Untreated maternal mental health issues during pregnancy pose significant risks. Informed discussions on medication are crucial for mother and baby's well-being.
The August Special Report emphasizes the urgent need for action beyond diversity in psychiatry, addressing systemic racism's profound impact on Black mental health.
Discover effective strategies for treating borderline personality disorder without intensive therapy, focusing on empowerment, structure, and human connection.
Altimmune's pemvidutide gains FDA Fast Track designation for alcohol use disorder.
H. Steven Moffic, MD, examines the psychological dynamics of hubris, humiliation, and revenge in global conflicts.
Explore effective strategies for managing narcolepsy, including personalized treatment plans, medication options, and lifestyle interventions for improved patient outcomes.
New research reveals how past trauma influences brain responses to stress, highlighting the importance of neural connectivity in mental health and coping strategies.
Nearly half of catatonia patients relapse within two years, highlighting the need for effective long-term management strategies and potential benefits of antipsychotics.
BioXcel Therapeutics advances BXCL501 for outpatient treatment of agitation in bipolar disorder and schizophrenia, receiving positive FDA feedback in its pre-sNDA meeting discussion.
Explore the intersection of Taylor Swift's music, relationships, and their impact on mental well-being in today's society.
FDA approves Tonmya, a groundbreaking fibromyalgia treatment, offering hope for pain relief after 15 years without new options.
Antidepressant treatment for late-life depression enhances cognitive functions like memory and learning, linking symptom relief to cognitive improvement.
AI chatbots pose significant mental health risks, often exacerbating issues like suicide, self-harm, and delusions, highlighting urgent regulatory needs.
What are the cultural implications of President Trump's Kennedy Center Honors selections?
Psychodynamically-informed pharmacotherapy is much more than “prescribing.”
Current crises threaten children's health and mental well-being globally, highlighting the urgent need for action and support from psychiatry and society.
The complexities of Huntington disease can pose challenges for diagnosis. Let's take a look at its neuropsychiatric symptoms and the need for comprehensive treatment strategies.
"Tonight their eyes meet with the spirit of sacred music..."
Discover the complexities of sleep-related eating disorder, its symptoms, triggers, and effective treatments for better sleep health.
Dysphoric milk ejection reflex (D-MER) causes brief emotional distress during breastfeeding, often misdiagnosed as postpartum depression, requiring better awareness and support.
Hurricane Katrina's legacy highlights the urgent need for trauma-informed mental health care in disaster recovery, addressing PTSD and long-term emotional impacts.
PharmaTher's KETARx gains FDA approval, paving the way for innovative ketamine treatments in pain management and mental health disorders.